Krystal Biotech
Stock Forecast, Prediction & Price Target
Krystal Biotech Financial Estimates
Krystal Biotech Revenue Estimates
Krystal Biotech EBITDA Estimates
Krystal Biotech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $50.69M 0% | Avg: $425.98M Low: $288.07M High: $543.78M avg. 740.22% | Avg: $602.76M Low: $412.70M High: $763.03M avg. 41.49% | Avg: $810.54M Low: $554.97M High: $1.02B avg. 34.47% | Avg: $987.17M Low: $675.90M High: $1.24B avg. 21.79% |
Net Income
% change YoY
| $-69.57M N/A | $-139.97M -101.20% | $10.93M 107.80% | Avg: $143.56M Low: $9.43M High: $259.20M avg. 1213.26% | Avg: $249.25M Low: $84.36M High: $337.46M avg. 73.61% | Avg: $308.32M Low: $181.94M High: $414.89M avg. 23.69% | Avg: $383.39M Low: $226.23M High: $515.90M avg. 24.34% |
EBITDA
% change YoY
| $-65.30M N/A | $-110.92M -69.83% | $17.90M 116.14% | Avg: $255.59M Low: $172.84M High: $326.27M avg. 1327.57% | Avg: $361.66M Low: $247.62M High: $457.81M avg. 41.49% | Avg: $486.32M Low: $332.98M High: $615.63M avg. 34.47% | Avg: $592.30M Low: $405.54M High: $749.78M avg. 21.79% |
EPS
% change YoY
| -$3.13 N/A | -$5.49 -75.39% | $0.4 107.28% | Avg: $5.51 Low: $0.34 High: $9.34 avg. 1276.38% | Avg: $8.63 Low: $3.04 High: $12.16 avg. 56.75% | Avg: $11.11 Low: $6.56 High: $14.95 avg. 28.73% | Avg: $13.82 Low: $8.15 High: $18.59 avg. 24.34% |
Operating Expenses
% change YoY
| $68.27M N/A | $120.19M 76.04% | $157.33M 30.89% | Avg: $497.73M Low: $336.58M High: $635.37M avg. 216.35% | Avg: $704.28M Low: $482.21M High: $891.54M avg. 41.49% | Avg: $947.06M Low: $648.44M High: $1.19B avg. 34.47% | Avg: $1.15B Low: $789.74M High: $1.46B avg. 21.79% |
FAQ
What is Krystal Biotech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 333.73% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 9.43M, average is 143.56M and high is 259.20M.
What is Krystal Biotech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 209.49% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $288.07M, average is $425.98M and high is $543.78M.
What is Krystal Biotech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 346.55% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $0.34, average is $5.51 and high is $9.34.
What is the best performing analyst?
In the last twelve months analysts have been covering Krystal Biotech stock. The most successful analyst is Dae Gon Ha.